About this trial
The study is a prospective registry. Consecutive patients with indications of implant / replacement or upgrade of pacemaker (PM), implantable cardioverter defibrillator (ICD), Implanted loop recorder (ILR) will be enrolled.
The primary objective of the study is to describe the clinical events during a long-term follow-up of non-selected population of patients implanted with an PM, ICD or ILR.
Eligibility criteria
Qualifiers
All consecutive patients underwent PM/ICD/ILR implantation
Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
Patient must be able to attend all required follow-up visits at the study center for at least 12 months
Disqualifiers
No informed consent
Patient is participating in another clinical study that may have an impact on the study endpoint
No informed consent
Trial design
Treatments tested in this trial
- Device implantation